$IVFH
INNOVATIVE FOOD HOLDINGS INC

2023 Q4 Form 10-Q Financial Statement

#000118518523001156 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $19.09M $17.30M
YoY Change -20.05% -13.76%
Cost Of Revenue $15.32M $12.42M
YoY Change -14.3% -20.08%
Gross Profit $3.770M $4.876M
YoY Change -37.16% 8.03%
Gross Profit Margin 19.75% 28.19%
Selling, General & Admin $3.679M $4.483M
YoY Change -21.88% 3.75%
% of Gross Profit 97.6% 91.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $127.3K $98.37K
YoY Change -7.93% 1.78%
% of Gross Profit 3.38% 2.02%
Operating Expenses $3.679M $4.483M
YoY Change -21.88% 3.75%
Operating Profit $90.63K $393.1K
YoY Change -92.97% 103.79%
Interest Expense -$219.0K $260.7K
YoY Change 5.86% 41.76%
% of Operating Profit -241.66% 66.33%
Other Income/Expense, Net $1.410K -$258.3K
YoY Change -53.92% 41.06%
Pretax Income -$1.478M $134.7K
YoY Change -235.09% 1282.44%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$1.675M $134.7K
YoY Change -253.01% 1282.44%
Net Earnings / Revenue -8.77% 0.78%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$0.03 $0.00
COMMON SHARES
Basic Shares Outstanding 48.98M shares 48.98M shares
Diluted Shares Outstanding 49.24M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.327M $3.710M
YoY Change 8.73% 34.79%
Cash & Equivalents $5.327M $3.712M
Short-Term Investments
Other Short-Term Assets $287.5K $339.4K
YoY Change -0.66% 0.91%
Inventory $2.973M $2.986M
Prepaid Expenses
Receivables $4.308M $4.969M
Other Receivables $0.00 $0.00
Total Short-Term Assets $13.64M $12.01M
YoY Change 3.25% 12.25%
LONG-TERM ASSETS
Property, Plant & Equipment $7.000M $7.683M
YoY Change -11.63% -4.06%
Goodwill
YoY Change
Intangibles $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $7.682M $9.790M
YoY Change -24.75% -7.99%
TOTAL ASSETS
Total Short-Term Assets $13.64M $12.01M
Total Long-Term Assets $7.682M $9.790M
Total Assets $21.32M $21.80M
YoY Change -8.95% 2.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.046M $5.020M
YoY Change -8.39% -13.98%
Accrued Expenses $783.5K $710.0K
YoY Change 132.89% 124.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $121.0K $139.1K
YoY Change -97.88% -97.56%
Total Short-Term Liabilities $8.641M $7.405M
YoY Change -47.35% -51.61%
LONG-TERM LIABILITIES
Long-Term Debt $8.855M $8.861M
YoY Change 466525.22%
Other Long-Term Liabilities $802.4K $910.0K
YoY Change 817.67% 326.47%
Total Long-Term Liabilities $8.855M $8.861M
YoY Change -44.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.641M $7.405M
Total Long-Term Liabilities $8.855M $8.861M
Total Liabilities $18.52M $17.39M
YoY Change 10.01% -44.26%
SHAREHOLDERS EQUITY
Retained Earnings -$38.82M -$37.15M
YoY Change 12.64% 4.46%
Common Stock $5.251K $5.159K
YoY Change 3.2% 2.02%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.141M $1.141M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $2.805M $4.403M
YoY Change
Total Liabilities & Shareholders Equity $21.32M $21.80M
YoY Change -8.95% 2.15%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$1.675M $134.7K
YoY Change -253.01% 1282.44%
Depreciation, Depletion And Amortization $127.3K $98.37K
YoY Change -7.93% 1.78%
Cash From Operating Activities $1.764M -$320.0K
YoY Change -19.93% -170.43%
INVESTING ACTIVITIES
Capital Expenditures $62.40K $30.00K
YoY Change 687.88% -308.04%
Acquisitions
YoY Change
Other Investing Activities $86.07K
YoY Change
Cash From Investing Activities $23.67K -$30.00K
YoY Change -398.86% 108.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -75.17K -2.120M
YoY Change 54.16% 4318.51%
NET CHANGE
Cash From Operating Activities 1.764M -320.0K
Cash From Investing Activities 23.67K -30.00K
Cash From Financing Activities -75.17K -2.120M
Net Change In Cash 1.713M -2.470M
YoY Change -20.22% -730.23%
FREE CASH FLOW
Cash From Operating Activities $1.764M -$320.0K
Capital Expenditures $62.40K $30.00K
Free Cash Flow $1.702M -$350.0K
YoY Change -22.48% -174.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Entity Registrant Name
EntityRegistrantName
INNOVATIVE FOOD HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity File Number
EntityFileNumber
0-9376
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1167761
dei Entity Address Address Line1
EntityAddressAddressLine1
28411 Race Track Rd.
dei Entity Address City Or Town
EntityAddressCityOrTown
Bonita Springs
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
34135
dei City Area Code
CityAreaCode
239
dei Local Phone Number
LocalPhoneNumber
596-0204
dei Security12b Title
Security12bTitle
N/A
dei Trading Symbol
TradingSymbol
N/A
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48979067 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3711887 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4899398 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4969374 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4969395 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
2986258 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
3053852 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
339410 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
289432 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
12006929 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
13212077 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7682896 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7921561 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
104775 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
152425 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
469883 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
570323 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30994 usd
CY2023Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1532822 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1532822 usd
CY2023Q3 us-gaap Assets
Assets
21797305 usd
CY2022Q4 us-gaap Assets
Assets
23420202 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5228965 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6853253 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
343144 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
0 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
91660 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
18104 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1094322 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1558155 usd
CY2023Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2014333 usd
CY2023Q3 ivfh Stock Appreciation Rights Liability
StockAppreciationRightsLiability
274755 usd
CY2022Q4 ivfh Stock Appreciation Rights Liability
StockAppreciationRightsLiability
0 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
120330 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
5711800 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
66860 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
64987 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
185226 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
191977 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7405262 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16412609 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
8880014 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 usd
CY2023Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
874359 usd
CY2022Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
0 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37915 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
87438 usd
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
197077 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
333092 usd
CY2023Q3 us-gaap Liabilities
Liabilities
17394627 usd
CY2022Q4 us-gaap Liabilities
Liabilities
16833139 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51622238 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49427297 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48799067 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46589717 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
5159 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4938 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
42685559 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
42189471 usd
CY2023Q3 ivfh Stock Shares Vested But Not Yet Issued
StockSharesVestedButNotYetIssued
180000 shares
CY2022Q4 ivfh Stock Shares Vested But Not Yet Issued
StockSharesVestedButNotYetIssued
1499940 shares
CY2023Q3 ivfh Common Stock Value To Be Issued
CommonStockValueToBeIssued
18 usd
CY2022Q4 ivfh Common Stock Value To Be Issued
CommonStockValueToBeIssued
150 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2623171 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2623171 shares
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
1141370 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1141370 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37146688 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34466126 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
4402678 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6587063 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21797305 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23420202 usd
CY2023Q3 us-gaap Revenues
Revenues
17300291 usd
CY2022Q3 us-gaap Revenues
Revenues
20059982 usd
us-gaap Revenues
Revenues
53128812 usd
us-gaap Revenues
Revenues
56226249 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12424105 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15546132 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39373204 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
43537570 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
4876186 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
4513850 usd
us-gaap Gross Profit
GrossProfit
13755608 usd
us-gaap Gross Profit
GrossProfit
12688679 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4483134 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4320981 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13838369 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15015456 usd
CY2023Q3 us-gaap Severance Costs1
SeveranceCosts1
0 usd
CY2022Q3 us-gaap Severance Costs1
SeveranceCosts1
0 usd
us-gaap Severance Costs1
SeveranceCosts1
1945650 usd
us-gaap Severance Costs1
SeveranceCosts1
0 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
4483134 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
4320981 usd
us-gaap Operating Expenses
OperatingExpenses
15784019 usd
us-gaap Operating Expenses
OperatingExpenses
15015456 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
393052 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
192869 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2028411 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2326777 usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2022Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
294000 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-40556 usd
CY2023Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
2389 usd
CY2022Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
785 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
6189 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
8169 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
260708 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
183908 usd
us-gaap Interest Expense
InterestExpense
642506 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
50680 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
165328 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
168000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
112169 usd
us-gaap Profit Loss
ProfitLoss
-2680562 usd
us-gaap Interest Expense
InterestExpense
379253 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-258319 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-183123 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-636317 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-117640 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
134733 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9746 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2664728 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2444417 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15834 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
134733 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
9746 usd
us-gaap Net Income Loss
NetIncomeLoss
-2680562 usd
us-gaap Net Income Loss
NetIncomeLoss
-2444417 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49193476 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47390976 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48909277 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46838377 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49235998 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47390976 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48909277 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46838377 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
5273430 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
152726 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
9746 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5435902 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
4190619 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
77326 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
134733 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
4402678 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
7410101 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
460269 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
59949 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
50000 usd
us-gaap Profit Loss
ProfitLoss
-2444417 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5435902 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6587063 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
4402678 usd
us-gaap Profit Loss
ProfitLoss
-2680562 usd
us-gaap Profit Loss
ProfitLoss
-2444417 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
429048 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
423844 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
47650 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
50821 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
70618 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2013 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
328177 usd
us-gaap Share Based Compensation
ShareBasedCompensation
520218 usd
ivfh Gain On Valuation Of Stock Appreciation Rights
GainOnValuationOfStockAppreciationRights
-274755 usd
ivfh Gain On Valuation Of Stock Appreciation Rights
GainOnValuationOfStockAppreciationRights
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-40556 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
108694 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
11493 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
108673 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1425374 usd
us-gaap Increase Decrease In Inventories And Other Operating Assets
IncreaseDecreaseInInventoriesAndOtherOperatingAssets
-17616 usd
us-gaap Increase Decrease In Inventories And Other Operating Assets
IncreaseDecreaseInInventoriesAndOtherOperatingAssets
-150643 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1489017 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
386414 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1385503 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-463833 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-536757 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-47650 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-50821 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2196279 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2802762 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58949 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
107045 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-58949 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-107045 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
50000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3285588 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
52405 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
169696 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
151133 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
130459 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
2014333 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
110305 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1067717 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-460460 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1187511 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3370267 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4899398 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6122671 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3711887 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2752404 usd
us-gaap Interest Paid Net
InterestPaidNet
572879 usd
us-gaap Interest Paid Net
InterestPaidNet
187090 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
ivfh Increase In Right Of Use Assets Liabilities
IncreaseInRightOfUseAssetsLiabilities
0 usd
ivfh Increase In Right Of Use Assets Liabilities
IncreaseInRightOfUseAssetsLiabilities
-13216 usd
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 usd
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
42500 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
0 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
7695866 usd
ivfh Par Value Of Shares Issued Previously Accrued
ParValueOfSharesIssuedPreviouslyAccrued
66 usd
ivfh Par Value Of Shares Issued Previously Accrued
ParValueOfSharesIssuedPreviouslyAccrued
0 usd
us-gaap Stock Issued1
StockIssued1
168000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of these unaudited consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate these estimates, including those related to revenue recognition and concentration of credit risk. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Accounts subject to estimate and judgements are accounts receivable reserves, inventory reserves, income taxes, intangible assets, operating and finance right of use assets and liabilities, and equity-based instruments. Actual results may differ from these estimates under different assumptions or conditions. We believe our estimates have not been materially inaccurate in past years, and our assumptions are not likely to change in the foreseeable future.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration:underline">Concentrations of Credit Risk</span></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and trade receivables. The Company places its cash and temporary cash in investments with credit quality institutions. At times, such investments may be in excess of applicable government mandated insurance limit. At September 30, 2023 and 2022, trade receivables from the Company’s largest customer amounted to 26% and 27%, respectively, of total trade receivables. During the three months ended September 30, 2023 and 2022, sales from the Company’s largest customer amounted to 47% and 50% of total sales, respectively. During the nine months ended September 30, 2023 and 2022, sales from the Company’s largest customer amounted to 47% and 51% of total sales, respectively.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company maintains cash balances in excess of Federal Deposit Insurance Corporation limits. At September 30, 2023 and December 31, 2022, the total cash in excess of these limits was $2,018,993 and $3,205,568, respectively.</p>
CY2023Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
2018993 usd
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
3205568 usd
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
1631406 usd
CY2022Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
700582 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-1081044 usd
CY2022Q1 us-gaap Deferred Revenue
DeferredRevenue
1250944 usd
CY2022Q2 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
99989 usd
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-128686 usd
CY2022Q2 us-gaap Deferred Revenue
DeferredRevenue
1222247 usd
CY2022Q3 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
385633 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-513231 usd
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
1094649 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
1558155 usd
CY2023Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
215346 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-534711 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
1238790 usd
CY2023Q2 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
361151 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-515819 usd
CY2023Q2 us-gaap Deferred Revenue
DeferredRevenue
1084122 usd
CY2023Q3 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
997195 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-986995 usd
CY2023Q3 us-gaap Deferred Revenue
DeferredRevenue
1094322 usd
CY2023Q3 us-gaap Revenues
Revenues
17300291 usd
CY2022Q3 us-gaap Revenues
Revenues
20059982 usd
us-gaap Revenues
Revenues
53128812 usd
us-gaap Revenues
Revenues
56226249 usd
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2150000 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P0Y4M13D
CY2022Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2300000 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P1Y3M29D
us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
1000307 shares
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37146688 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2196279 usd
ivfh Working Capital Deficit
WorkingCapitalDeficit
4601667 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
134733 usd
us-gaap Net Income Loss
NetIncomeLoss
-2680562 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
9746 usd
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5051214 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5309620 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
81840 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
340225 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4969374 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4969395 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
335693 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
57789 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
108694 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
11493 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
60186 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2986258 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3053852 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
2986258 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
3053852 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10626190 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10567243 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2943294 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2645682 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7682896 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7921561 usd
CY2023Q3 us-gaap Depreciation
Depreciation
98367 usd
CY2022Q3 us-gaap Depreciation
Depreciation
96650 usd
us-gaap Depreciation
Depreciation
297614 usd
us-gaap Depreciation
Depreciation
285215 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
17746 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
18213 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
54282 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
15536 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
15659 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
47650 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
50821 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
104775 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
152425 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
104775 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
152425 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
66860 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
64987 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37915 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
87438 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
71902 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
37936 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
890 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
110728 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5953 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
104775 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
13216 usd
ivfh Lease Cost Table Text Block1
LeaseCostTableTextBlock1
The Company has financing leases for vehicles and warehouse equipment. Right of use asset – financing leases are summarized below:<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3437" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" id="new_id-3438" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>September 30,</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2023</b></p> </td> <td id="new_id-3439" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td id="new_id-3440" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" id="new_id-3441" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>December 31,</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2022</b></p> </td> <td id="new_id-3442" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3443" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" id="new_id-3444" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(unaudited)</p> </td> <td id="new_id-3445" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3446" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3447" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3448" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3449" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 62%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vehicles</p> </td> <td id="new_id-3450" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3451" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td id="new_id-3452" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">404,858</td> <td id="new_id-3453" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3454" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3455" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td id="new_id-3456" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">404,858</td> <td id="new_id-3457" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Warehouse Equipment</p> </td> <td id="new_id-3458" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3459" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3460" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">555,416</td> <td id="new_id-3461" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3462" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3463" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3464" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">555,416</td> <td id="new_id-3465" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total before accumulated depreciation</p> </td> <td id="new_id-3466" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3467" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3468" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">960,274</td> <td id="new_id-3469" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3470" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3471" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3472" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">960,274</td> <td id="new_id-3473" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; white-space: nowrap;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less: accumulated depreciation</p> </td> <td id="new_id-3474" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3475" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3476" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(490,391</td> <td id="new_id-3477" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> <td id="new_id-3478" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3479" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td id="new_id-3480" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(389,951</td> <td id="new_id-3481" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; white-space: nowrap;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total</p> </td> <td id="new_id-3482" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3483" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3484" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">469,883</td> <td id="new_id-3485" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> <td id="new_id-3486" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td id="new_id-3487" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td id="new_id-3488" style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">570,323</td> <td id="new_id-3489" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt; white-space: nowrap;"> </td> </tr> </table>
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
960274 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
960274 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
490391 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
389951 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
469883 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
570323 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
33480 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
37128 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
100440 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
107736 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
42500 usd
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
382303 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
525069 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
185226 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
191977 usd
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
197077 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
333092 usd
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
382303 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
525069 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
183376 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
151982 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
36150 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
10795 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
382303 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6066399 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-4533567 usd
CY2023Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1532822 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2492465 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-928649 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1563816 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10332 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10231 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30994 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30993 usd
CY2023Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
5021343 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
6599903 usd
CY2023Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
207622 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
253350 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5228965 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6853253 usd
CY2023Q1 ivfh Payments Of Separation Costs
PaymentsOfSeparationCosts
250000 usd
us-gaap Severance Costs1
SeveranceCosts1
1945650 usd
ivfh Payments Of Separation Costs
PaymentsOfSeparationCosts
-728546 usd
CY2023Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
1217104 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
343144 usd
CY2023Q3 us-gaap Other Employee Related Liabilities Current And Noncurrent
OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent
874359 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
120330 usd
CY2023Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.085 pure
CY2023Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2014333 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
9384134 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5711800 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
383790 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
9000344 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
5711800 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
139131 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5711800 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8861213 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
9000344 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
5711800 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
109597 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
120708 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
132951 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
146313 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
8754235 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
9384134 usd
CY2023Q3 ivfh Common Stock Issued But Not Outstanding
CommonStockIssuedButNotOutstanding
2823171 shares
CY2022Q4 ivfh Common Stock Issued But Not Outstanding
CommonStockIssuedButNotOutstanding
2823171 shares
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
667320 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
267030 shares
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
112169 usd
CY2023Q1 ivfh Numberof Employees
NumberofEmployees
3 pure
ivfh Number Of Directors
NumberOfDirectors
2 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51622238 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48799067 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.137 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0429 pure
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y10M28D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.039 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0445 pure
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y7M17D
CY2022Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
33445 shares
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
11405 usd
CY2022Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
142857 shares
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
48544 usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49427297 shares
CY2022Q3 ivfh Stock Shares Vested But Not Yet Issued
StockSharesVestedButNotYetIssued
1189293 shares
CY2023Q3 us-gaap Share Price
SharePrice
0.72
CY2022Q3 us-gaap Share Price
SharePrice
0.19
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1500000 shares
CY2019Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
50000000 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000312257

Files In Submission

Name View Source Status
0001185185-23-001156-index-headers.html Edgar Link pending
0001185185-23-001156-index.html Edgar Link pending
0001185185-23-001156.txt Edgar Link pending
0001185185-23-001156-xbrl.zip Edgar Link pending
ex_588686.htm Edgar Link pending
ex_588687.htm Edgar Link pending
ex_588688.htm Edgar Link pending
ex_588689.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
innovfood20230930_10q.htm Edgar Link pending
ivfh-20230930.xsd Edgar Link pending
ivfh_logo1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ivfh-20230930_cal.xml Edgar Link unprocessable
ivfh-20230930_def.xml Edgar Link unprocessable
ivfh-20230930_lab.xml Edgar Link unprocessable
ivfh-20230930_pre.xml Edgar Link unprocessable
innovfood20230930_10q_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending